Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease
To demonstrate whether or not tolvaptan modifies ADPKD development as measured via adjustments from baseline (from trial 156-04-251) in whole kidney extent (TKV) and renal function.
